Apellis Pharmaceuticals (APLS) News Today $23.13 -0.69 (-2.90%) Closing price 04:00 PM EasternExtended Trading$23.27 +0.14 (+0.61%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Goldman Sachs Group Inc. Purchases 64,742 Shares of Apellis Pharmaceuticals, Inc. $APLSSeptember 16 at 4:10 AM | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Acquired by Woodline Partners LPSeptember 15 at 4:00 AM | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) Shares Down 4.1% - What's Next?September 13, 2025 | marketbeat.comWhen Can We Expect A Profit From Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)?September 12, 2025 | finance.yahoo.comVoleon Capital Management LP Buys New Position in Apellis Pharmaceuticals, Inc. $APLSSeptember 12, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Sold by Royal Bank of CanadaSeptember 12, 2025 | marketbeat.comBayforest Capital Ltd Grows Stock Holdings in Apellis Pharmaceuticals, Inc. $APLSSeptember 11, 2025 | marketbeat.comOctagon Capital Advisors LP Cuts Stock Position in Apellis Pharmaceuticals, Inc. $APLSSeptember 11, 2025 | marketbeat.comTeza Capital Management LLC Invests $259,000 in Apellis Pharmaceuticals, Inc. $APLSSeptember 11, 2025 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), ACADIA Pharmaceuticals (ACAD)September 10, 2025 | theglobeandmail.comApellis Pharmaceuticals, Inc. (APLS) Presents At Baird Global Healthcare Conference (Transcript)September 9, 2025 | seekingalpha.comFocus Partners Advisor Solutions LLC Makes New $363,000 Investment in Apellis Pharmaceuticals, Inc. $APLSSeptember 9, 2025 | marketbeat.comGranahan Investment Management LLC Acquires 21,278 Shares of Apellis Pharmaceuticals, Inc. $APLSSeptember 8, 2025 | marketbeat.comAlyeska Investment Group L.P. Takes Position in Apellis Pharmaceuticals, Inc. $APLSSeptember 8, 2025 | marketbeat.comGraham Capital Management L.P. Takes Position in Apellis Pharmaceuticals, Inc. $APLSSeptember 8, 2025 | marketbeat.comAQR Capital Management LLC Purchases 2,220,977 Shares of Apellis Pharmaceuticals, Inc. $APLSSeptember 7, 2025 | marketbeat.comNorthern Trust Corp Has $11.34 Million Stock Holdings in Apellis Pharmaceuticals, Inc. $APLSSeptember 7, 2025 | marketbeat.comJames George Chopas Sells 548 Shares of Apellis Pharmaceuticals (NASDAQ:APLS) StockSeptember 5, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. (APLS) Presents At Cantor Global Healthcare Conference 2025 (Transcript)September 4, 2025 | seekingalpha.com683 Capital Management LLC Reduces Stake in Apellis Pharmaceuticals, Inc. $APLSSeptember 4, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. (APLS) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeptember 3, 2025 | seekingalpha.comPDT Partners LLC Buys 57,471 Shares of Apellis Pharmaceuticals, Inc. $APLSSeptember 3, 2025 | marketbeat.comBraidwell LP Sells 446,532 Shares of Apellis Pharmaceuticals, Inc. $APLSSeptember 3, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Bought by Canada Pension Plan Investment BoardSeptember 3, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Sold by Hsbc Holdings PLCSeptember 3, 2025 | marketbeat.comTrexquant Investment LP Has $8.42 Million Holdings in Apellis Pharmaceuticals, Inc. $APLSSeptember 2, 2025 | marketbeat.comLandscape Capital Management L.L.C. Reduces Stake in Apellis Pharmaceuticals, Inc. $APLSSeptember 2, 2025 | marketbeat.comRafferty Asset Management LLC Trims Stake in Apellis Pharmaceuticals, Inc. $APLSSeptember 1, 2025 | marketbeat.comRussell Investments Group Ltd. Raises Stake in Apellis Pharmaceuticals, Inc. $APLSSeptember 1, 2025 | marketbeat.comSiren L.L.C. Sells 237,862 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 31, 2025 | marketbeat.comIeq Capital LLC Buys 165,148 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 31, 2025 | marketbeat.comApellis Pharmaceuticals (NASDAQ:APLS) CEO Cedric Francois Sells 49,963 SharesAugust 30, 2025 | insidertrades.comApellis Pharmaceuticals, Inc. (NASDAQ:APLS) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 30, 2025 | marketbeat.comStocks To Watch: Apellis Pharmaceuticals Sees Relative Strength Rating Rise To 81August 27, 2025 | msn.comApellis Pharmaceuticals, Inc. $APLS Shares Acquired by Old West Investment Management LLCAugust 27, 2025 | marketbeat.comJump Financial LLC Purchases New Stake in Apellis Pharmaceuticals, Inc. $APLSAugust 27, 2025 | marketbeat.comApellis Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 27, 2025 | globenewswire.comAlphaQuest LLC Increases Stock Holdings in Apellis Pharmaceuticals, Inc. $APLSAugust 26, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Sold by Candriam S.C.A.August 25, 2025 | marketbeat.comNuveen LLC Invests $10.77 Million in Apellis Pharmaceuticals, Inc. $APLSAugust 25, 2025 | marketbeat.comInvesco Ltd. Purchases 37,741 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 25, 2025 | marketbeat.com9,577 Shares in Apellis Pharmaceuticals, Inc. $APLS Purchased by Kaufman Rossin Wealth LLCAugust 24, 2025 | marketbeat.comApellis Pharmaceuticals, Inc. $APLS Shares Sold by Swiss National BankAugust 24, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 32,249 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 24, 2025 | marketbeat.comApellis Pharmaceuticals Shows Market Leadership With Jump To 82 RS RatingAugust 22, 2025 | msn.comShort Interest in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Grows By 34.0%August 22, 2025 | marketbeat.comFox Run Management L.L.C. Makes New Investment in Apellis Pharmaceuticals, Inc. $APLSAugust 22, 2025 | marketbeat.comVanguard Group Inc. Grows Stake in Apellis Pharmaceuticals, Inc. $APLSAugust 22, 2025 | marketbeat.comInsider Selling: Apellis Pharmaceuticals (NASDAQ:APLS) General Counsel Sells 5,000 Shares of StockAugust 21, 2025 | marketbeat.comAlgert Global LLC Buys 56,328 Shares of Apellis Pharmaceuticals, Inc. $APLSAugust 20, 2025 | marketbeat.com Get Apellis Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for APLS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. APLS Media Mentions By Week APLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APLS News Sentiment▼1.420.92▲Average Medical News Sentiment APLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APLS Articles This Week▼119▲APLS Articles Average Week Get the Latest News and Ratings for APLS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Apellis Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RDY News ASND News VTRS News QGEN News BBIO News ROIV News ELAN News VRNA News MRNA News RVMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APLS) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
